Trade Summary

2 days ago, Laviolette Paul A, serving as CEO at Pulse Biosciences, Inc. (PLSE), purchased 15,000 shares at $19.69 per share, for a total transaction value of $295,350.00. Following this transaction, Laviolette Paul A now holds 15,000 shares of PLSE.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 11, 2026, meaning the disclosure happened on the same day as the trade.

Pulse Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.